Product NDC: | 51808-125 |
Proprietary Name: | In-111 DTPA |
Non Proprietary Name: | In-111 DTPA |
Active Ingredient(s): | 3.75 mCi/1.5mL & nbsp; In-111 DTPA |
Administration Route(s): | INTRATHECAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51808-125 |
Labeler Name: | AnazaoHealth Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20120619 |
Package NDC: | 51808-125-01 |
Package Description: | 1.5 mL in 1 VIAL (51808-125-01) |
NDC Code | 51808-125-01 |
Proprietary Name | In-111 DTPA |
Package Description | 1.5 mL in 1 VIAL (51808-125-01) |
Product NDC | 51808-125 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | In-111 DTPA |
Dosage Form Name | SOLUTION |
Route Name | INTRATHECAL |
Start Marketing Date | 20120619 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | AnazaoHealth Corporation |
Substance Name | INDIUM IN-111 PENTETATE DISODIUM |
Strength Number | 3.75 |
Strength Unit | mCi/1.5mL |
Pharmaceutical Classes | Lead Chelating Activity [MoA],Lead Chelator [EPC] |